Tag Archives: Coronavirus

Africa COVID-19 deaths surpass 100,000 after second wave

JOHANNESBURG (Reuters) – Africa’s reported COVID-19 death toll surpassed 100,000 on Friday, a fraction of those reported on other continents but rising fast as a second wave of infections overwhelms hospitals.

The continent’s reported deaths, at 100,354, compare favorably with North America, which has registered more than half a million, and Europe, which is approaching 900,000, a Reuters tally shows.

But deaths are rising sharply across Africa, driven by its southern region, especially economic powerhouse South Africa, which accounts for nearly half. South Africa was ravaged by a second wave caused by a more contagious variant that has jammed up casualty wards.

“The increased number (of infections) has led to many severe cases and some of the countries really found it quite difficult to cope,” Richard Mihigo, coordinator of the immunization program at the World Health Organization’s Africa office, told Reuters.

“We have seen some countries getting to their limit in terms of oxygen supply, which has got a really negative impact in terms of case management for severe cases.”

Mihigo said the rise in deaths was pronounced in countries near South Africa like Zimbabwe, Mozambique and Malawi, raising the possibility that the 501Y.V2 variant identified in South Africa late last year had spread through the southern Africa region – although more genomic sequencing needs to be carried out to prove that.

International aid group Doctors Without Borders (MSF) this month called for urgent vaccine distributions in southern Africa to counter the spread of the new variant, as most African countries have lagged richer Western nations in launching mass vaccination programs.

Reuters data show Africa’s case fatality rate is now at around 2.6%, higher than the global average of 2.3%, and marginally up on the 2.4% rate after the first wave of infections – which at the time compared favorably with other continents.

Experts caution against reading too much into the data – the real toll may be much higher or lower. For instance, South Africa’s excess deaths – deaths considered over-and-above the normal rate – during the pandemic have reached over 137,000, almost three times its official COVID-19 death toll.

Then again, in some cases Africa’s low testing rates could inflate its true case fatality rate (CFR), said Professor Francisca Mutapi, an infectious disease expert at the University of Edinburgh.

“If deaths being registered as COVID-19 deaths are not necessarily contingent on a positive test … as is the case in South Africa, then this can drive up CFR,” she said.

Even with these caveats acknowledged, African countries look like they are struggling with COVID-19 more than last year.

“Are we counting all the deaths on the continent? No … but most people on the continent do know somebody who has died of COVID during this second wave,” Africa CDC director John Nkengasong told reporters last week.

“Hospitals are being overwhelmed due to health systems that are fragile.”

(Reporting by Alexander Winning, Tim Cocks and Wendell Roelf; Writing by Tim Cocks; Editing by Nick Macfie, Angus MacSwan and Jane Wardell)

India virus infections at three-week high, Mumbai hires marshals to enforce mask-wearing

NEW DELHI (Reuters) – India reported on Friday its biggest jump in new coronavirus infections in three weeks, with 13,193 cases, while thousands of marshals fanned out to enforce mask wearing across the financial capital of Mumbai, which is battling a recent spurt.

The tally of confirmed infections is 10.96 million, the second highest after the United States, with more than 156,000 deaths. But actual infections could range as high as 300 million, a government serological survey showed this month.

In recent days, 75% of India’s new cases have been reported from the southern state of Kerala and Maharashtra, home to Mumbai, a densely populated city of 20 million people. The two states already had the highest number of reported infections.

Health experts suggest the re-opening of educational institutes in Kerala and resumption of suburban train services in Mumbai could be key factors.

After a gap of 11 months, Mumbai resumed on Feb. 1 full suburban train services, which before the pandemic carried a daily average of 8 million people.

The city has begun hiring marshals to enforce mask wearing. Out of nearly 5,000 marshals, around 300 would be deployed on the rail network, city authorities said.

Indians have largely given up on masks and social distancing, Reuters reporting shows.

“Coronavirus … has not yet left the country,” the health ministry said on Twitter. “We still need to follow COVID-appropriate behavior. No carelessness till there is a cure.”

Despite the recent rise in infections, India’s daily tally of new cases remains well below a mid-September peak of nearly 100,000. Testing numbers have also fallen to about 800,000 a day from more than 1 million.

Since starting its vaccine campaign in mid-January, India has administered nearly 10 million doses, aiming to cover 300 million people by August.

(Reporting by Krishna N. Das and Anuron Kumar Mitra; Editing by Simon Cameron-Moore)

‘I just ask God to help me’: Texas funeral home crushed by death as U.S. COVID toll nears 500,000

By Callaghan O’Hare and Maria Caspani

HOUSTON (Reuters) – Sunday is traditionally a quiet day for Chuck Pryor’s Houston funeral home, but on this Sunday in February, almost a year after the global pandemic reached Texas, the phone was still ringing.

Pryor took the call: COVID-19 had taken yet another American life — pushing the nation’s death toll closer to the half-million mark — and another grieving family required the services of the exhausted funeral director and his staff.

“It’s just mentally taxing,” Pryor, 59, who runs a small funeral home business with his wife Almika, told Reuters earlier this month.

The sheer number of coronavirus deaths has overwhelmed many U.S. funeral homes. Some family-owned businesses have handled a crushing case load, with some seeing the same number of deaths in a couple of months as they would normally handle in a full year, said Dutch Nie, a spokesperson with the National Funeral Directors Association.

“Most funeral home directors know that it’s a 24-hour, 365-day career, but you’re just not used to every single day working those hours,” Nie told Reuters.

The pandemic has brought profound changes to the way Pryor must operate. Overloaded hospitals want bodies to be removed quickly. It has been difficult to find trained staff, caskets and protective equipment. And every day brings a multitude of phone calls from families in pain and distress.

As the virus showed no sign of releasing its grip and deaths mounted over the summer and in the fall, exhausted workers at Pryority Funeral Experience fell ill while others quit.

“People quit because they mentally can’t handle it,” he said. “I pray God, — just give me strength… I want to run away right now, to be honest …I’m concerned about myself breaking down so I just ask God to help me.”

Sometimes the stories he hears on the job haunt him.

Like the one he was told when he answered a COVID-19 call on a recent weekend in The Woodlands, a suburb of Houston.

A young woman in her 30s had just died from complications from the virus, a while after doctors performed a C-section to save the life of her twins as her condition deteriorated.

The following day, Pryor was having a hard time processing the tragedy, one of the hundreds of thousands that have marked a year of profound loss across the entire country, and the world.

“I slept with it last night and I hate that, you know, when you take them to bed,” he said.

NEVER SO BUSY

Pryor said he had never been as busy as during the pandemic. The deaths the funeral home handled in 2020 were more than double those he would see in a normal year.

January was a terrible month. Even as hospitalizations in Texas fell by 10% last month from a 36% rise in December, coronavirus deaths increased by 48%, according to a Reuters analysis of state and county data.

“I do pace myself and I do turn people down because I can only do so much,” Pryor said.

His staff of four full-time employees and eight part-timers is feeling the strain, he said.

Embalmers and others who come directly into contact with bodies and are at higher risk of contagion, have been hard to find, Pryor said. And caskets are in short supply due to the pandemic. On a Thursday earlier this month, Pryor’s uncle drove four hours from Dallas to deliver eight of them.

The job is so consuming, Pryor said, there is little time left to perform the most essential personal tasks, like cooking or spending time with his soon-to-be 10-year-old son.

While caring for those who lost loved ones in his community, Pryor’s family was faced with their own grief. The virus took his nephew and his uncle while his wife lost her cousin and her aunt to COVID-19.

‘HOOKED’ ON HELPING PEOPLE

Pryor grew up in rural Texas, the youngest of six and the only one of his siblings who did not attend segregated schools. His first brush with the funeral business was in the late 1970’s when he would help illiterate members of his community with their mail and bills at the local funeral home on the first of every month.

“I got hooked in helping people when they need help the most,” Pryor said.

Since he started his own business in 1984, celebrating life even in death had always been front and center in his profession, he said. But the coronavirus pandemic turned everything “upside down,” making it even more difficult to help people through the grieving process.

In late January, Pryor and his team handled the funeral arrangements for Gregory Blanks, a 50-year-old COVID-19 victim who ran a heating and air conditioning business in the Houston area. He was a huge fan of the Dallas Cowboys football team.

In keeping with current restrictions to prevent infections, only a limited number of family and friends were able to attend the burial at San Felipe Community Cemetery where a preacher spoke next to a table lined with baseball caps for the Cowboys and other Texas teams.

Clad in a face mask sporting the logo of her husband’s company, Blanks’ wife Lila solemnly watched as some of Pryor’s workers lowered the casket into the ground.

“People, they can’t hug,” Pryor said. “They cry and no one’s there to wipe your tears.”

(Reporting by Maria Caspani in New York and Callaghan O’Hare in Houston, additional reporting by Anurag Maan in Bengaluru; Writing by Maria Caspani; Editing by Lisa Shumaker)

Pfizer study deals new blow to South Africa’s vaccine hopes

By Alexander Winning and Wendell Roelf

JOHANNESBURG (Reuters) – Scientists will meet on Thursday to advise South Africa’s government on its next steps after a study suggested the dominant local coronavirus variant may reduce antibody protection from Pfizer’s COVID-19 vaccine by two-thirds.

The laboratory study, published in the New England Journal of Medicine, dealt a new blow to the country hardest-hit by the pandemic on the African continent.

The government and its advisers must weigh whether to wait for vaccines that might be more effective against the more infectious 501Y.V2 variant, or try to vaccinate people quickly to avert further infections and deaths.

South Africa had been counting on the Pfizer shot, developed with German partner BioNTech, to step up its vaccination program after administering the first Johnson & Johnson (J&J) doses on Wednesday.

Earlier this month, it placed AstraZeneca vaccinations on hold because of interim data showing its jab offered minimal protection against mild to moderate illness from the 501Y.V2 variant first identified late last year.

Officials are more confident about the J&J shot because it was shown to be effective in preventing severe illness in the local leg of a large global trial.

The detailed laboratory study published on Wednesday took into account all key mutations of the 501Y.V2 variant. A paper published in late January assessed the impact of only three key mutations of the variant on the Pfizer vaccine.

Scientists said that because the new study’s findings come from a laboratory, it is not easy to extrapolate what they might mean for the shot’s efficacy in the real world.

“Our scientists will be meeting to discuss it (the study) and they will advise the minister,” health ministry spokesman Popo Maja said.

Barry Schoub, a professor and chair of the Ministerial Advisory Committee on vaccines, said the committee would discuss the study alongside information on other COVID-19 vaccines.

Asked to comment on the findings, he said: “The Pfizer vaccine is enormously effective at 95%, so even if there is quite a significant reduction there still will be quite a bit of remnant efficacy left.”

“It is very likely that it will protect to a reasonable extent, certainly against severe illness and mild to moderate to some extent,” he said.

“STRONG ENOUGH”

Richard Mihigo, an immunization official at the World Health Organization’s Africa office, told a news conference the antibody response to the variant in the Pfizer study was “strong enough”.

Linda-Gail Bekker, co-lead investigator of the South African arm of J&J’s global trial, said she would recommend rolling out the Pfizer vaccine but monitoring it in the same way as the J&J shot, which is being administered in an “implementation study” targeting up to 500,000 health workers to further test it in the field.

“We should make sure we do see the effectiveness we (are) hoping for,” she told Reuters.

Health Minister Zweli Mkhize said on Wednesday South Africa was expecting 500,000 doses of the Pfizer vaccine initially and about 7 million doses by June.

A spokesman for regulator SAHPRA said Pfizer’s registration application was under review and declined further comment.

South Africa, with nearly 1.5 million cases and about 48,500 deaths, has recorded almost half the COVID-19 fatalities and over a third of confirmed infections in Africa. It lagged richer Western nations in launching its immunization campaign.

The government plans to vaccinate 40 million people – two-thirds of the population.

“Luckily there are a range of vaccines available and what we will do is work with the national authorities to understand the implications of this (study) and see what they need to do,” the WHO’s Africa director, Matshidiso Moeti, said.

(Reporting by Alexander Winning in Johannesburg and Wendell Roelf in Cape Town; Additional reporting by Kate Kelland in London, Ludwig Burger in Frankfurt and Aaron Ross in Dakar; Editing by Olivia Kumwenda-Mtambo, Angus MacSwan, Raju Gopalakrishnan and Timothy Heritage)

Switzerland plans cautious easing of pandemic lockdown from March

By John Revill and John Miller

ZURICH (Reuters) – Switzerland plans to make its first “cautious steps” towards ending its coronavirus lockdown next month, the government said on Wednesday, contrasting with neighbors that are sticking with many restrictions.

In the first step, shops, museums and libraries are due to reopen from March 1. Zoos, gardens and sports facilities will also be reopened, with a final decision to come on Feb. 24.

Ministers have been caught being caught between health experts supporting stricter limits and struggling businesses calling for a reopening, but an easing in the number of infections has allowed the government to change course.

“The efforts of the last few months are now paying off, the population has been very disciplined,” said Health Minister Alain Berset.

“New infections have halved within a month, so the situation is not so bad. We would all like to do more activities again, such as sports.”

With the initial reopening, private events with up to 15 people would also be allowed, said the government, up from the current limit of five.

Switzerland’s reopening contrasts with neighboring Austria which will decide on March 1 on a potential loosening of pandemic restrictions that happen around Easter, at the earliest.

“We’re taking a risk, but we think that’s acceptable as long as everybody plays along,” Berset told a press conference in Bern.

Additional easing from April 1 could follow if infections remain low, he added.

Measures to cushion the economic impact of the pandemic will push Switzerland into a 15.8 billion Swiss franc ($17.59 billion) deficit for 2020, due mainly to higher spending and lower tax receipts.

Still, the government said it would expand its spending to deal with the pandemic, which has so far claimed 9,128 lives.

It has decided to expand support package for large companies hit hard by the crisis, ramping up a compensation scheme to 10 billion francs, from 5 billion francs previously.

($1 = 0.8981 Swiss francs)

(Reporting by John Revill and John Miller, editing by Mihcael Shields)

UK PM Johnson wants ‘cautious but irreversible’ path out of COVID-19 lockdown

By Guy Faulconbridge and Kate Holton

LONDON (Reuters) – British Prime Minister Boris Johnson said on Monday he would plot a cautious but irreversible path out of the COVID-19 lockdown this week after the vaccination of 15 million vulnerable people.

With nearly a quarter of the United Kingdom’s population now inoculated with a first dose of a COVID vaccine in a little over two months, Johnson is under pressure from some lawmakers and businesses to reopen the shuttered economy.

“We’ve got to be very prudent and what we want to see is progress that is cautious, but irreversible,” Johnson told reporters. “If we possibly can, we’ll be setting out dates.”

“If because of the rate of infection, we have to push off something a little bit to the right – delay it for a little bit – we won’t hesitate to do that.”

Johnson, due to set the path out of lockdown on Feb. 22, said the rates of infection were still high and too many people were still dying.

Asked if he would ensure schools reopened on March 8, Johnson said he would do everything he could to ensure that.

If many people get infected, there would be a high risk of mutation in the virus and higher risk of it spreading to older and more vulnerable groups, he said.

The biggest and swiftest global vaccine rollout in history is seen as the best chance of exiting the COVID-19 pandemic which has killed 2.4 million people, tipped the global economy into its worst peacetime slump since the Great Depression, and upended normal life for billions.

The United Kingdom has the world’s fifth-worst official death toll – currently 117,166 – after the United States, Brazil, Mexico and India.

VACCINE PASSPORTS?

Britain has vaccinated 15.062 million people with a first dose and 537,715 with a second dose, the fastest rollout per capita of any large country. Hancock said he expected vaccine supplies to increase as manufacturing accelerated.

An influential group of lawmakers in Johnson’s Conservative Party is urging an end to the lockdown as soon as the most vulnerable nine groups are vaccinated. They want no more rules beyond May 1.

“We’re all filled with sorrow for the people we’ve lost, the harms that we’ve suffered but we don’t honor those we’ve loved and lost by wrecking the rest of our lives,” lawmaker Steve Baker said. “We’ve got to find a way to rebuild our society and our economy and our prospects, our livelihoods.”

Britain is speaking to other countries about giving its citizens certificates showing they have been vaccinated so that they can travel abroad in the future to countries that require them, Johnson said.

“That’s going to be very much in the mix, down the road I think that is going to happen,” Johnson said, referring to such certificates. “What I don’t think we will have in this country is, as it were, vaccination passports to allow you to go to the pub, or something like that.”

(Reporting by Guy Faulconbridge and Kate Holton; Editing by Peter Graff, Nick Macfie and Bernadette Baum)

Hundreds in Serbia mourn medics, demand better COVID protection

BELGRADE (Reuters) – Hundreds of people held a minute’s silence in front of Serbia’s government building on Monday to pay their respects to doctors and nurses killed by COVID-19 and to demand more is done to protect health workers.

People placed white roses at the entrance to the building and lit candles.

Of the 4,245 people who have died in Serbia from COVID-19, around 2.5% or 105 were doctors, according to official figures.

The Union of Doctors and Pharmacists, which organized the protest, says the death toll among doctors is higher than in other countries in the region.

“For a small country such as Serbia, this is a huge number of people we have lost because of bad organization,” said Ferenci Tot, a respiratory diseases specialist, who was among the protest organizers.

In neighboring Croatia only one doctor has died from COVID-19, in Albania 24 doctors have died and in Bosnia 23 doctors, according to local media reports.

Doctor Dejan Zujovic, a pulmonologist who has worked in COVID-19 red zones in Belgrade, said long working hours and poor protection equipment were the main reasons for such a high death rate among doctors.

“People do not go on holidays, they are exhausted and their immunity suffers,” he said.

Government officials have said they will investigate the deaths of medical workers but little has been done so far.

The head of the government’s Crisis Committee, Predrag Kon, drew public criticism when he said doctors and nurses became infected while having coffee rather than while working with patients.

To prevent further deaths, hours spent in COVID-19 red zones should be limited to six a day, with a one-month time limit on rotas, said Doctor Gorica Djokic, a secretary general of the Union of Doctors and Pharmacists.

(Reporting by Ivana Sekularac; Editing by Janet Lawrence)

Exclusive: UK auditing Indian vaccine site amid scramble for shots-sources

By Neha Arora, Krishna N. Das and Euan Rocha

NEW DELHI (Reuters) – Britain’s drug regulator is auditing manufacturing processes at Serum Institute of India (SII) which could pave the way for AstraZeneca’s COVID-19 vaccine to be shipped from there to the UK and other countries, according to two sources close to the matter.

SII, the world’s largest vaccine manufacturer, is currently mass producing the AstraZeneca vaccine, developed in conjunction with Oxford University, for dozens of poor and middle-income countries but not the UK, which has been getting its supply of the shot primarily from domestic facilities.

If the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) gives SII’s manufacturing process for the Oxford/AstraZeneca shot a greenlight it would allow the drug to be exported to the UK and to other countries which recognize MHRA’s clearances, one of the sources said.

Reuters could not determine what was the rationale for the audit. SII did not respond to a request for comment on it. The MHRA confirmed that an inspection was happening but declined further comment.

“Due to commercial confidentiality we do not comment on inspections that are still ongoing,” the regulator’s chief executive Dr. June Raine said in a statement to Reuters.

The two sources, who asked not to be named as the matter is private, said the audit should be relatively routine for SII, as its site already supplies other vaccines to the UK.

The inspection comes as countries around the world scramble to secure vaccine supplies amid supply disruptions and delivery cuts from leading drugmakers such as Pfizer Inc, Moderna and AstraZeneca.

It was not immediately clear whether an MHRA approval would allow the UK or AstraZeneca to route SII volumes of COVISHIELD – the brand name under which SII markets the AstraZeneca shot – to the EU, which has been pressuring the UK for supply from AstraZeneca’s facilities in the UK, amid shortages in Europe.

AstraZeneca executives told EU officials last week that to accelerate supplies to the bloc, it could provide it with some doses manufactured outside Europe, two EU sources told Reuters. One said the SII could be a supplier.

AstraZeneca, which has previously tapped SII to help fulfill some of its vaccine orders from Brazil, South Africa and Saudi Arabia, did not respond to a request for comment on whether it needs SII to help meet commitments in the UK, or in any other nations that would recognize an MHRA certification.

It was not immediately available to comment on the reported offer to supply the EU with shots from the SII.

INSPECTIONS

The EU’s drug regulator, the European Medicines Agency (EMA), audits sites from which it plans to source medicines but during the global pandemic, with multiple COVID-19 vaccines being developed, it is also partly leaning on inspections carried out by some other international regulators.

“Inspection outcomes for Covid-19 vaccines conducted by the MHRA will be considered by EMA,” said the regulator. Any such approved sites would also need an EMA sign off before they can export to the EU, the regulator told Reuters.

MHRA declined to comment on specifics, but Raine said it was collaborating “with international partners in response to the global pandemic and on matters of mutual interest.”

The UK has expressed an interest in purchasing vaccines from SII, according to the second source, along with a government official in New Delhi. The two sources said the volumes or timelines for any such purchases were unclear.

A UK government spokeswoman said: “Any discussions that have taken place between the UK Government and India on vaccines are not related to securing extra vaccine supply to the UK.”

The UK has so far ordered 100 million doses of AstraZeneca’s vaccine.

“Most countries have approached us and India’s government,” SII told Reuters, but it did not comment on any UK outreach. “We are trying our best to meet demand, and supply the vaccine to as many countries as possible, keeping India as the priority.”

SII’s chief executive, Adar Poonawalla, told Reuters in late January, his family-owned firm was keen to support AstraZeneca’s supply needs but its primary focus was on India and other poorer nations in Asia and Africa. He said at the time SII had no plans to divert supplies to Europe.

(Neha Arora and Krishna N.Das reported from New Delhi and Euan Rocha reported from Mumbai; Additional reporting by Paul Sandle, Kate Kelland and Alistair Smout in London, Francesco Guarascio in Brussels and Ludwig Burger in Frankfurt; Editing by Carmel Crimmins)

WHO says all hypotheses still open in probe into virus origins

By Reuters Staff

GENEVA (Reuters) – – All hypotheses are still open in the World Health Organization’s search for the origins of COVID-19, WHO Director-General Tedros Adhanom Ghebreyesus told a briefing on Friday.

A WHO-led mission in China said this week that it was not looking further into the question of whether the virus escaped from a lab, which it considered highly unlikely. The United States has said it will review the mission’s findings.

“Some questions have been raised as to whether some hypotheses have been discarded. Having spoken with some members of the team, I wish to confirm that all hypotheses remain open and require further analysis and study,” Tedros said.

“Some of that work may lie outside the remit and scope of this mission. We have always said that this mission would not find all the answers, but it has added important information that takes us closer to understanding the origins of the COVID-19 virus,” he said.

The mission has said its main hypotheses are that the virus originated in a bat, although there are several possible scenarios for how it passed to humans, possibly first by infecting another species of animal.

The former administration of U.S. President Donald Trump said it believed the virus may have escaped from a lab in the Chinese city of Wuhan. China has strongly denied this, and says the Wuhan Institute of Virology was not studying related viruses.

Overflowing Czech hospitals seek patient transfers as ‘UK variant’ rages

By Robert Muller

NACHOD, Czech Republic (Reuters) – Jan Mach had coped with his eastern Czech district hospital’s COVID-19 wards filling up – until 22 new arrivals on Monday alone were too much and he had to seek outside help.

On Wednesday, ambulances took 15 patients to hospitals as much as 230 km (140 miles) away, as closer ones were also packed.

“We have been close to our ceiling in the past 14 days, we have touched it several times,” director Mach said, adding the 339-bed hospital had 120 COVID-19 patients. “On Monday alone we took in 22 patients and that was beyond our means.”

Nachod and Trutnov, neighboring districts on the Polish border 150 km east of Prague, are among several regions that have seen incessant spread of the disease, despite a national lockdown.

A new, more infectious variant of the virus first detected in Britain is the likely reason – data from January showed between 45% and 60% of new patients were infected with the UK variant.

On Friday, the region of 550,000 reported just four free beds in COVID-19 wards and eight in high dependency and intensive care units (ICUs) treating coronavirus patients.

“We are taking in patients in a more serious condition and younger patients, I mean born 1970 and later, we had not seen that in the autumn,” Mach said.

Patients who would normally be treated in high-dependency units or ICU have had to be given therapies such as high-flow oxygen on normal wards due to the shortage of beds.

Mach spoke minutes after overseeing another ICU patient being transferred to another hospital. Staff dressed in full-body protective gear pushed the trolley past piles of equipment boxes, one of them with the hand-written label “body bags.”

The Czech Republic has ranked among the European countries worst-hit by the pandemic. Only Portugal has reported more new cases per capita in the past two weeks, according to the European Centre for Disease Prevention and Control (ECDC).

As of Friday morning, the country of 10.7 million had reported 17,902 COVID-19 related deaths.

Still, the parliament voted on Thursday not to extend a national state of emergency, which will lift some of current lockdown measures including the closure of shops, a loosely policed ban on gatherings and a night-time curfew.

Petr Stepanek, chief surgeon in the resuscitation unit at Nachod hospital, said the situation was “very tense”.

“It is about the ‘British’ variant,” Stepanek said. “If a majority of the population has already had it, thank God. If not, then the situation can become very dramatic.”

(Reporting by Robert Muller; Writing by Jan Lopatka; Editing by Alex Richardson)